LONDEN–(BUSINESS WIRE)– WEP Clinical (WEP), een gespecialiseerd dienstverlenend bedrijf dat samenwerkt met sponsors om patiënten en artsen te helpen vroegtijdig toegang te krijgen tot medicijnen wanneer er geen andere behandelingsopties beschikbaar zijn, heeft Karl Challender aangesteld als Chief Operating Officer van het bedrijf. Karl is aangesteld om de wereldwijde activiteiten van het bedrijf te leiden en de groei- en ontwikkelingsstrategie van WEP vooruit te helpen.

Karl heeft meer dan 25 jaar ervaring in de farmaceutische en klinische onderzoek sector en brengt een schat aan functionele ervaring met zich mee op gebieden als Operations, Finance, Logistics, Project Management en Sales. Voordat hij bij WEP kwam, werkte Karl met organisaties als Novartis, Alcon en meest recentelijk Worldwide Clinical Trials, waar hij een belangrijke rol speelde bij de succesvolle groei van de organisatie.

WEP Clinical Appoints Karl Challender as Chief Operating Officer

LONDON–(BUSINESS WIRE)– WEP Clinical (WEP), a specialist services company that works with sponsors to help patients and physicians gain early access to medicines when no other treatment options are available, has appointed Karl Challender as the company’s Chief Operating Officer. Karl has been brought on to lead the company’s global operations and drive WEP’s growth and development strategy moving forward.

Karl has over 25 years of experience in the pharmaceutical and clinical research industry and brings with him a wealth of functional experience covering areas including Operations, Finance, Logistics, Project Management and Sales. Prior to joining WEP, Karl worked with organisations including Novartis, Alcon, and most recently Worldwide Clinical Trials, where he was instrumental in the successful growth of the organisation.

Jaswinder Khera, Managing Director of WEP, said:

“WEP has grown rapidly over the last few years. We are excited to see this continue and are confident that Karl’s expansive industry experience and expertise will help elevate our position as the global leader in Expanded Access and Named Patient Programs. Karl is an excellent addition to our team and his passion for patient service and delivery excellence is well aligned with our company ethos and goals.”

About WEP

Established in 2008, WEP is a specialist services company that works with drug developers to help patients and physicians gain early access to medicines when no other treatment options are available. We have offices located in London, United Kingdom; RTP North Carolina, United States; Lisbon, Portugal; and Dublin, Ireland and possess all the necessary licenses allowing us to meet drug access and distribution needs across all regions, worldwide. We are passionate about helping those in need. For more information, please visit www.wepclinical.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220405005667/en/

Contacts

For further information, please contact:

Yasmin Khera
Tel: +44 208 004 8185

Email: info@wepclinical.com
Company Video: www.wepclinical.com/company-video/